Page last updated: 2024-08-23

razoxane and Cardiovascular Diseases

razoxane has been researched along with Cardiovascular Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, M; Kim, KI; Oh, JM; Shin, WG; Song, YC1
Champion, C; Durand, JB; Ewer, MS; Gibbs, H; Lenihan, DJ; Swafford, J; Tong, AT; Yeh, ET; Yusuf, SW; Zafarmand, AA1
Cvetković, RS; Scott, LJ1
Huang, X; Katz, SD; Zhang, Q; Zheng, H1
Sullivan, JL1
Steinherz, L1
Anandasbapathy, S; Elihu, N; Frishman, WH1

Reviews

3 review(s) available for razoxane and Cardiovascular Diseases

ArticleYear
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
    Circulation, 2004, Jun-29, Volume: 109, Issue:25

    Topics: Anthracyclines; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biomarkers; Biopsy; Cardiovascular Diseases; Cytokines; Heart; Humans; Neoplasms; Pericardium; Radiation Injuries; Radiotherapy; Razoxane; Risk Factors

2004
Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy.
    Drugs, 2005, Volume: 65, Issue:7

    Topics: Anthracyclines; Antineoplastic Agents; Cardiovascular Agents; Cardiovascular Diseases; Humans; Neoplasms; Randomized Controlled Trials as Topic; Razoxane

2005
Chelation therapy in cardiovascular disease: ethylenediaminetetraacetic acid, deferoxamine, and dexrazoxane.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:2

    Topics: Antibiotics, Antineoplastic; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Deferoxamine; Doxorubicin; Edetic Acid; Female; Humans; Iron; Razoxane

1998

Trials

1 trial(s) available for razoxane and Cardiovascular Diseases

ArticleYear
Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Adult; Anemia, Iron-Deficiency; Brachial Artery; Cardiovascular Diseases; Chelating Agents; Double-Blind Method; Endothelium, Vascular; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Homocysteine; Humans; Iron; Male; Methionine; Nitroglycerin; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Transferrin; Tyrosine; Vasodilation

2006

Other Studies

3 other study(ies) available for razoxane and Cardiovascular Diseases

ArticleYear
Cardioprotective effect of early dexrazoxane use in anthracycline treated pediatric patients.
    Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:5

    Topics: Adolescent; Age Factors; Anthracyclines; Cardiovascular Agents; Cardiovascular Diseases; Child; Child, Preschool; Female; Heart Function Tests; Hospitals, Teaching; Humans; Infant; Male; Neoplasms; Razoxane; Republic of Korea; Retrospective Studies

2012
Is homocysteine an iron-dependent cardiovascular risk factor?
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Adult; Cardiovascular Diseases; Chelating Agents; Endothelium, Vascular; Female; Ferritins; Homocysteine; Humans; Iron; Iron Deficiencies; Male; Methionine; Oxidative Stress; Razoxane; Regional Blood Flow; Risk Factors; Sex Characteristics; Vasodilation

2006
Early breast cancer therapy and cardiovascular injury.
    Journal of the American College of Cardiology, 2008, Mar-25, Volume: 51, Issue:12

    Topics: Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotonic Agents; Cardiovascular Diseases; Female; Humans; Razoxane; Treatment Outcome

2008